Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.8150 (1.31%) ($10.5750 - $10.8150) on Wed. Dec. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.68% (three month average) | RSI | 24 | Latest Price | $10.8150(1.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(19%) URA(17%) XLK(17%) BLOK(16%) VUG(15%) | Factors Impacting BCRX price | BCRX will decline at least -1.84% in a week (0% probabilities). SMH(-28%) ARKG(-22%) VIXM(-9%) SHY(-8%) GLD(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.84% (StdDev 3.68%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.43(-140.96%) | Resistance Level | $11.46 | 5 Day Moving Average | $10.79(0.23%) | 10 Day Moving Average | $10.83(-0.14%) | 20 Day Moving Average | $11.46(-5.63%) | To recent high | -23.9% | To recent low | 3.3% | Market Cap | $1.908b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |